Default company panoramic image
Logo

MyoStim

Reducing Amputations and Diabetic Wounds by augmenting the body’s own natural bioelectric system to enhance healing and regeneration.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location San Diego, CA, USA
  • Currency USD
  • Founded November 2011
  • Employees 4
  • Website myostimpacers.com

Company Summary

MyoStim's patented Limb Salvage System is designed to reduce the incidence of amputations and recurrence of chronic wounds. There are over 139,000 non-traumatic related amputations annually in the United States and 50% of diabetes related wounds treated with standard therapies recur within 2 yrs. Our proposal will provide a permanent solution and save limbs and lives at a lower cost.

Team

  • Default avatar
    Alan Remen
    CEO

    Mr. Remen is a business founder and serial entrepreneur with C level management experience in aerospace, agriculture, data communications, telecommunications, industrial instrumentation, out-sourced engineering, and Medical Device industries. In his aerospace company, Mr. Remen pioneered the reclamation of expensive hydraulic and dielectric fluids for the U.S. Military. In his agriculture company, Mr. Remen pioneered the continuous feeding of cro

  • Default avatar
    Howard Leonhardt
    CTO

    An inventor and serial entrepreneur with over 20 patents for products for treating cardiovascular and heart disease. His TALENT stent graft for aortic aneurysm repair has treated over 120,000 patients worldwide since it's introduction in 1994 and holds a world leading market share today as part of Medtronic Vascular. In 1983 Leonhardt was Export Sales Manager, and the first founding employee, of American General Medical Corporation in Hardeeville

  • Default avatar
    David Kramer
    CFO

    Mr. Kramer’s CFO experience spans 25 years of helping companies grow from start-up to over $100 million in sales, from high tech to life sciences. Most recently, he was CFO at Somanta Pharmaceuticals, Inc., a start-up, where he helped take the company through a reverse merger onto the NASDAQ. Earlier, at Anadys Pharmaceuticals, Inc., an emerging company, as CFO he helped raise $38 million in venture capital. Previously, at Gen-Probe, Inc., an

  • Default avatar
    Dennis Bandyk MD, FACS
    Chief Medical Officer

    Section Head, Division of Vascular & Endovascular Surgery
    Professor of Surgery
    Sulpizio Cardiovascular Center
    University of California San Diego

    Dennis Bandyk, MD, is a Professor of Surgery at the University of California San Diego School of Medicine and Chief, Division of Vascular & Endovascular Surgery located at the Sulpizio Family Cardiovascular Center. He received his undergraduate (BSE–Aerospace Engineering), masters (MSE-Bioenginee

Advisors

  • Default avatar
    Mike Brown, Stradling Yocca Carlson Rauth
    Lawyer
    Unconfirmed

Previous Investors

  • Default avatar
    Alan Remen
    Unconfirmed
    Default avatar
    Howard Leonhardt
    Unconfirmed